This protocol is judged by an institutional evaluate board, an impartial group that critiques any medical trials involving individuals. If a review will involve a Program I drug, after the board approves the protocol as moral, the scientists need to make an application for an investigational new drug (IND) amount with the FDA.Luckily, other compan